Shopping Cart 0
Cart Subtotal
AED 0

University of Southampton - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

University of Southampton (UOS) is an educational institution that offers education and research services. The institute provides educational programs in the fields of accounting and finance, acoustical engineering, aeronautics and astronautics, anthropology, archaeology, biochemistry, biology, biomedical sciences, chemistry, civil engineering, computer science and software engineering, among others. It also offers venues, catering and hospitality, and outreach and volunteering programmes for schools, and other groups. UOS partners with other universities, charities and government bodies. The institute has operations across Southampton, the UK. UOS is headquartered in Southampton, the UK.

University of Southampton-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Southampton, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Southampton, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of Southampton, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Destiny Pharma Enters into Research Collaboration with University of Southampton 10

BioInvent Enters into Research Agreement with University of Southampton 11

BioInvent And CRT Enter Into Research Agreement With University Of Southampton 12

C4X Discovery Enters Into Agreement With University of Southampton For New Cyclic Peptides 13

Licensing Agreements 14

BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 14

University of Southampton-Key Competitors 15

University of Southampton-Key Employees 16

University of Southampton-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Government and Public Interest 18

Sep 21, 2018: Southampton gets GBP125k dementia research funding boost 18

Jun 05, 2018: LU receives USD 397,800 NIH grant for tinnitus relief research 19

May 03, 2018: New research shows that one of the most widely used treatments for childhood eczema is not helpful 21

Mar 27, 2018: A combination of cancer immunotherapies could save more lives 23

Nov 16, 2017: New talking therapy could help cancer survivors cope after treatment 25

Sep 15, 2017: 'Exciting' discovery on path to develop new type of vaccine to treat global viruses 26

Aug 22, 2017: Studies highlight 'potential new targets for immunotherapy' 28

Aug 03, 2017: Scientists deliver knock-out blow to multiple cancers 29

Aug 01, 2017: Doctors develop pioneering nose drop to help fight meningitis 30

Jul 13, 2017: Scientists make breakthrough in reversing treatment resistance in blood cancer patients 32

Product News 34

Aug 11, 2017: Experimental drug trial seeks to improve treatment for lymphoma 34

Feb 07, 2017: Researchers use tiny 3-D spheres to combat tuberculosis 36

Other Significant Developments 37

Jul 31, 2018: Blockchain-Based Pilot for Exchange of Clinical Data Announced by Grapevine World in Collaboration With the University of Southampton and Tiani Spirit 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

University of Southampton, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Southampton, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

University of Southampton, Pharmaceuticals & Healthcare, Key Facts 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Southampton, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Southampton, Deals By Therapy Area, 2012 to YTD 2018 8

University of Southampton, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Destiny Pharma Enters into Research Collaboration with University of Southampton 10

BioInvent Enters into Research Agreement with University of Southampton 11

BioInvent And CRT Enter Into Research Agreement With University Of Southampton 12

C4X Discovery Enters Into Agreement With University of Southampton For New Cyclic Peptides 13

BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 14

University of Southampton, Key Competitors 15

University of Southampton, Key Employees 16

University of Southampton, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

University of Southampton, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

University of Southampton (UOS) is an educational institution that offers education and research services. The institute provides educational programs in the fields of accounting and finance, acoustical engineering, aeronautics and astronautics, anthropology, archaeology, biochemistry, biology, biomedical sciences, chemistry, civil engineering, computer science and software engineering, among others. It also offers venues, catering and hospitality, and outreach and volunteering programmes for schools, and other groups. UOS partners with other universities, charities and government bodies. The institute has operations across Southampton, the UK. UOS is headquartered in Southampton, the UK.

University of Southampton-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Southampton, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Southampton, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of Southampton, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Destiny Pharma Enters into Research Collaboration with University of Southampton 10

BioInvent Enters into Research Agreement with University of Southampton 11

BioInvent And CRT Enter Into Research Agreement With University Of Southampton 12

C4X Discovery Enters Into Agreement With University of Southampton For New Cyclic Peptides 13

Licensing Agreements 14

BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 14

University of Southampton-Key Competitors 15

University of Southampton-Key Employees 16

University of Southampton-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Government and Public Interest 18

Sep 21, 2018: Southampton gets GBP125k dementia research funding boost 18

Jun 05, 2018: LU receives USD 397,800 NIH grant for tinnitus relief research 19

May 03, 2018: New research shows that one of the most widely used treatments for childhood eczema is not helpful 21

Mar 27, 2018: A combination of cancer immunotherapies could save more lives 23

Nov 16, 2017: New talking therapy could help cancer survivors cope after treatment 25

Sep 15, 2017: 'Exciting' discovery on path to develop new type of vaccine to treat global viruses 26

Aug 22, 2017: Studies highlight 'potential new targets for immunotherapy' 28

Aug 03, 2017: Scientists deliver knock-out blow to multiple cancers 29

Aug 01, 2017: Doctors develop pioneering nose drop to help fight meningitis 30

Jul 13, 2017: Scientists make breakthrough in reversing treatment resistance in blood cancer patients 32

Product News 34

Aug 11, 2017: Experimental drug trial seeks to improve treatment for lymphoma 34

Feb 07, 2017: Researchers use tiny 3-D spheres to combat tuberculosis 36

Other Significant Developments 37

Jul 31, 2018: Blockchain-Based Pilot for Exchange of Clinical Data Announced by Grapevine World in Collaboration With the University of Southampton and Tiani Spirit 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

University of Southampton, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Southampton, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

University of Southampton, Pharmaceuticals & Healthcare, Key Facts 2

University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Southampton, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Southampton, Deals By Therapy Area, 2012 to YTD 2018 8

University of Southampton, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Destiny Pharma Enters into Research Collaboration with University of Southampton 10

BioInvent Enters into Research Agreement with University of Southampton 11

BioInvent And CRT Enter Into Research Agreement With University Of Southampton 12

C4X Discovery Enters Into Agreement With University of Southampton For New Cyclic Peptides 13

BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 14

University of Southampton, Key Competitors 15

University of Southampton, Key Employees 16

University of Southampton, Subsidiaries 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

University of Southampton, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.